US 7538108
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
granted A61KA61K31/5383A61K31/675
Quick answer
US patent 7538108 (Prodrugs of 2,4-pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/5383, A61K31/675, A61P, A61P1/04